PVI
DNA icon

Pura Vida Investments’s Ginkgo Bioworks DNA Stock Holding History

Pura Vida Investments’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-18,750
Closed -$8.69M – 255
2021
Q3 		$8.69M Buy
+18,750
New +$9.13M 0.26% 101

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

Pura Vida Investments's DNA Position: Q4 2021 in Review

Pura Vida Investments sold out of Ginkgo Bioworks (DNA) in Q4 2021, closing a stake of 18,750 shares — an estimated $8.69M sold.

Pura Vida Investments first reported a position in DNA in Q3 2021 and held it in 1 quarter. The position peaked at $8.69M in Q3 2021. 164 funds tracked by Wall St. Rank hold DNA as of Q4 2021.

  • Pura Vida Investments reported no remaining Ginkgo Bioworks position as of Q4 2021 after selling out during the quarter.
  • Pura Vida Investments sold 18,750 Ginkgo Bioworks shares in Q4 2021, an estimated $8.69M.
  • Pura Vida Investments first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 1 quarter.
  • Pura Vida Investments's Ginkgo Bioworks position peaked at $8.69M in Q3 2021.
  • 164 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2021.

Based on Pura Vida Investments's 13F filing for Q4 2021, filed 14 Feb 2022.